International health insurance and GLP-1 — expat coverage guide

amsterdam_pete, first: take a breath. You have options. This is unfortunately becoming more common as employers try to cut costs.

Immediate steps:

1. Request a transition supply. Most states require insurers to provide 30-90 days of a medication that's being removed from formulary, especially if abrupt discontinuation poses health risks. Call Anthem and formally request this.
2. Check if the Wegovy savings card non-coverage path works for you. Novo's savings card offers Wegovy at ~$500/month for patients with commercial insurance that doesn't cover it. Not cheap, but better than $1,349.
3. Contact Novo Nordisk's patient support line (1-866-310-7549) and explain the situation. They have bridge programs for patients experiencing coverage disruptions.

Medium-term options:

• Ask your doctor to rewrite the prescription for Ozempic (semaglutide for diabetes) if you have any qualifying diagnosis — prediabetes, insulin resistance, T2D. Different formulary category.
• Consider compounded semaglutide as a bridge — $100-200/month
• Talk to HR about the decision and advocate for reversal at next plan renewal

One more angle: if your employer plan is subject to the ACA's essential health benefit requirements (fully-insured plans, not self-insured), there may be state mandates requiring coverage continuity for ongoing treatments. Check your state's insurance regulations.

For self-insured plans (common in larger employers), ERISA preempts state mandates. But there's still a fiduciary duty argument — the employer has a duty to act in the best interest of plan participants. Removing a medication class that's actively improving health outcomes is arguably a breach of that duty.

I'm NOT suggesting you sue your employer. But a well-crafted letter from an attorney citing fiduciary concerns can sometimes get HR to reconsider. Many employment lawyers offer free consultations for benefits disputes.

Also: check your Summary Plan Description (SPD) for the current year. If the plan year started January 1 and they're changing formulary April 1, there may be a violation of their own plan terms. Mid-year formulary changes are restricted in many plan designs.

Thank you both. I just called Anthem and requested the transition supply. The rep was actually helpful — she said I'm entitled to 90 days at my current copay under their transition of care policy. That buys me until July.

amy_econ_NJ — I pulled up my SPD and our plan year is Jan 1 - Dec 31. The formulary change effective April 1 does seem to contradict the SPD, which lists the formulary as of January 1. I'm going to bring this up with HR.

Meanwhile, my doctor said she can prescribe Ozempic instead of Wegovy. My A1C of 5.2 technically puts me in the "normal" range now, but she said with my history of prediabetes (A1C was 6.4 before Wegovy), she can justify Ozempic for "diabetes prevention." Is this likely to be covered even with the formulary change?

It depends on whether your employer excluded ALL GLP-1s or specifically GLP-1s prescribed for weight management. If the exclusion is indication-based (weight management only), then Ozempic prescribed for prediabetes/diabetes prevention should still be covered under the diabetes formulary.

This is actually a very common workaround. The active ingredient in Wegovy and Ozempic is identical — semaglutide. The difference is the indication, dosing, and which formulary bucket it falls into.

Important caveats:

• Ozempic max dose is 2mg; Wegovy goes to 2.4mg. If you're on Wegovy 2.4mg, you'd need to step down slightly.
• Your doctor needs to code the prescription appropriately (prediabetes/IR codes)
• Anthem may still require a PA for Ozempic

Have your doctor submit the PA for Ozempic while your 90-day transition supply is running. That way there's no gap.